In thyroid cancer patients with distant metastasis, the ability to concentrate radioiodine and to synthesize and secrete Tg is decreased (tumor cell de-differentiation), leading to poor response to radioiodine therapy and difficulty in monitoring the disease based on serum Tg level [34,35]. The gene discussed is TG; the disease is neoplasm.